Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trialThe lancet oncology, 2013-08, Vol.14 (9), p.823-833 [Peer Reviewed Journal]Elsevier Ltd ;2013 Elsevier Ltd ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2013 ;ISSN: 1470-2045 ;ISSN: 1474-5488 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(13)70274-2 ;PMID: 23850491 ;CODEN: LANCAOFull text available |
|
2 |
Material Type: Article
|
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical TrialClinical infectious diseases, 2022-09, Vol.75 (4), p.690-701 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab988 ;PMID: 34864943Full text available |
|
3 |
Material Type: Article
|
Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus InfectionTransplantation, 2016-10, Vol.100 (10), p.e74 [Peer Reviewed Journal]EISSN: 1534-6080 ;DOI: 10.1097/TP.0000000000001418 ;PMID: 27495775Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsCochrane database of systematic reviews, 2008-01 (2), p.CD003774 [Peer Reviewed Journal]EISSN: 1469-493X ;DOI: 10.1002/14651858.CD003774.pub3 ;PMID: 18425894Full text available |
|
5 |
Material Type: Article
|
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trialInternational journal of cancer, 2019-09, Vol.145 (6), p.1538 [Peer Reviewed Journal]2019 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.32230 ;PMID: 30801698Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical TrialClinical infectious diseases, 2022-03, Vol.74 (5), p.757-765 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2021 ;The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciab574 ;PMID: 34228099Full text available |
|
7 |
Material Type: Article
|
CMV: Prevention, Diagnosis and TherapyAmerican journal of transplantation, 2013-02, Vol.13 (s3), p.24-40 [Peer Reviewed Journal]Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons ;Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.12006 ;PMID: 23347212Full text available |
|
8 |
Material Type: Article
|
Filociclovir is a potent inhibitor of human adenovirus F41Antiviral research, 2022-12, Vol.208, p.105431 [Peer Reviewed Journal]Copyright © 2022 Elsevier B.V. All rights reserved. ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2022.105431 ;PMID: 36209985Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19Antiviral research, 2020-08, Vol.180, p.104857 [Peer Reviewed Journal]Copyright © 2020 Elsevier B.V. All rights reserved. ;EISSN: 1872-9096 ;DOI: 10.1016/j.antiviral.2020.104857 ;PMID: 32562705Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant RecipientsThe Journal of infectious diseases, 2024-02, Vol.229 (2), p.413-421 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2023 ;The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiad293 ;PMID: 37506264Full text available |
|
11 |
Material Type: Article
|
Activation of the STING-Dependent Type I Interferon Response Reduces Microglial Reactivity and NeuroinflammationNeuron (Cambridge, Mass.), 2017-12, Vol.96 (6), p.1290-1302.e6 [Peer Reviewed Journal]2017 Elsevier Inc. ;Copyright © 2017 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 20, 2017 ;ISSN: 0896-6273 ;EISSN: 1097-4199 ;DOI: 10.1016/j.neuron.2017.11.032 ;PMID: 29268096Full text available |
|
12 |
Material Type: Article
|
Survival in Patients with Glioblastoma Receiving ValganciclovirThe New England journal of medicine, 2013-09, Vol.369 (10), p.985-986 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc1302145 ;PMID: 24004141Full text available |
|
13 |
Material Type: Article
|
How I treat T-cell chronic active Epstein-Barr virus diseaseBlood, 2018-06, Vol.131 (26), p.2899-2905 [Peer Reviewed Journal]2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2018-03-785931 ;PMID: 29712633Full text available |
|
14 |
Material Type: Article
|
Cytomegalovirus after kidney transplantation in 2020: moving towards personalized preventionNephrology, dialysis, transplantation, 2022-04, Vol.37 (5), p.810-816 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the ERA-EDTA. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the ERA-EDTA. ;ISSN: 0931-0509 ;EISSN: 1460-2385 ;DOI: 10.1093/ndt/gfaa249 ;PMID: 33280028Full text available |
|
15 |
Material Type: Article
|
The Best Method for CMV Prevention in High-risk Kidney Transplant Recipients? Either, per National Norwegian Transplant Database: Commentary on Blom et al, Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic ManagementTransplantation, 2023-08, Vol.107 (8), p.1671 [Peer Reviewed Journal]EISSN: 1534-6080 ;DOI: 10.1097/TP.0000000000004616 ;PMID: 37211634Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Antiviral Drug Resistance of Human CytomegalovirusClinical Microbiology Reviews, 2010-10, Vol.23 (4), p.689-712 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright © 2010, American Society for Microbiology 2010 ;ISSN: 0893-8512 ;EISSN: 1098-6618 ;DOI: 10.1128/CMR.00009-10 ;PMID: 20930070 ;CODEN: CMIREXFull text available |
|
17 |
Material Type: Article
|
Emergence of letermovir resistance in a lung transplant recipient with ganciclovir‐resistant cytomegalovirus infectionAmerican journal of transplantation, 2018-12, Vol.18 (12), p.3060-3064 [Peer Reviewed Journal]2018 The American Society of Transplantation and the American Society of Transplant Surgeons ;2018 The American Society of Transplantation and the American Society of Transplant Surgeons. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.15135 ;PMID: 30286286Full text available |
|
18 |
Material Type: Article
|
Cell and Tissue Specific Metabolism of Nucleoside and Nucleotide Drugs: Case Studies and Implications for Precision MedicineDrug metabolism and disposition, 2023-03, Vol.51 (3), p.360-368 [Peer Reviewed Journal]Copyright © 2023 by The American Society for Pharmacology and Experimental Therapeutics. ;ISSN: 0090-9556 ;EISSN: 1521-009X ;DOI: 10.1124/dmd.122.000856 ;PMID: 36446610Full text available |
|
19 |
Material Type: Article
|
Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loadsJournal of antimicrobial chemotherapy, 2022-02, Vol.77 (2), p.466-473 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. ;ISSN: 0305-7453 ;EISSN: 1460-2091 ;DOI: 10.1093/jac/dkab419 ;PMID: 35107143Full text available |
|
20 |
Material Type: Article
|
Cytomegalovirus infection in transplant recipients: newly approved additions to our armamentariumClinical microbiology and infection, 2023-01, Vol.29 (1), p.44-50 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved. ;ISSN: 1198-743X ;EISSN: 1469-0691 ;DOI: 10.1016/j.cmi.2022.07.001 ;PMID: 35843567Digital Resources/Online E-Resources |